PATENT CLAIM ANALYSIS

Application Number: 15973783
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "715000"]

Abstract:
This invention concerns a method for treatment or prevention of lower urinary tract symptoms with or without pelvic pain in an individual, said method comprising administering to the individual an effective amount of a selective estrogen receptor modulator, or an isomer, isomer mixture or a pharmaceutically acceptable salt thereof.

Claim (Index 4):
The method according to  claim 1  wherein the lower urinary tract symptoms are abacterial prostatitis, stress prostatitis, trigonitis or orchialgia in male individuals.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 93.0
- Lexical Diversity: 1.325
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14832649', '13970026', '14597453', '14496281', '15626774']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7730968467035658
- 35 USC 102 Novelty (BERT): 0.6046899932995332
- Combined Prediction Score: 0.7562561613631625
- Mean Citation Score: 445.13821800000005
- Max Citation Score: 598.7485
- Similarity Product: 448.2011468284132

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test